EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024
|
EQS-Ad-hoc: Fresenius SE & Co. KGaA / Key word(s): Change in Forecast Fresenius SE & Co. KGaA: Fresenius raises outlook for fiscal year 2024
Fresenius raises its full-year outlook due to the excellent first quarter and a better than originally expected operating performance for the remainder of the fiscal year 2024. Fresenius now expects organic group revenue growth between 4 and 7% for the fiscal year 2024 (previously: 3 to 6%). Group EBIT at constant currency is now expected to grow between 6 and 10% (previously: 4 to 8%). The increase of the group outlook is based on improved business prospects for Fresenius Kabi. Fresenius Kabi now expects organic revenue growth in the mid to high single-digit percentage range for fiscal year 2024 (previously: mid single-digit percentage range). The EBIT margin is now expected to range between 15 and 16% (previously: around 15%). The adjustment of the group outlook also reflects the fact that the forecast is now provided without Fresenius Vamed, i.e. exclusively for the operating companies Fresenius Kabi and Fresenius Helios. Following the announcement of the planned divestment of Fresenius Vamed’s rehabilitation business, Fresenius has initiated its structured exit from its investment company Fresenius Vamed. For additional information on the performance indicators used please refer to our website at https://www.fresenius.com/alternative-performance-measures. Fresenius SE & Co. KGaA, represented by Fresenius Management SE, The Management Board Bad Homburg v.d.H., May 7, 2024 ---------------------------------------- Contact: Markus Georgi Senior Vice President Investor Relations T: +49 (0) 6172 608-2485 markus.georgi@fresenius.com ---------------------------------------- End of Note End of Inside Information
07-May-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Fresenius SE & Co. KGaA |
| Else-Kröner-Straße 1 | |
| 61352 Bad Homburg v.d.H. | |
| Germany | |
| Phone: | +49 (0)6172 608-2485 |
| Fax: | +49 (0)6172 608-2488 |
| E-mail: | ir-fre@fresenius.com |
| Internet: | www.fresenius.com |
| ISIN: | DE0005785604 |
| WKN: | 578560 |
| Indices: | DAX |
| Listed: | Regulated Market in Dusseldorf, Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Hamburg, Hanover, Stuttgart, Tradegate Exchange; Luxembourg Stock Exchange |
| EQS News ID: | 1898031 |
| End of Announcement | EQS News Service |
|
|
1898031 07-May-2024 CET/CEST
Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.
| The most important financial data at a glance | ||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | ||
| Sales1 | 37.250,00 | 36.277,00 | 37.520,00 | 40.840,00 | 22.299,00 | 21.833,00 | 22.860,00 | |
| EBITDA1,2 | 7.083,00 | 7.132,00 | 6.854,00 | 6.808,00 | 3.422,00 | 2.489,00 | 0,00 | |
| EBITDA-Margin3 | 19,02 | 19,66 | 18,27 | 16,67 | 15,35 | 11,40 | 0,00 | |
| EBIT1,4 | 4.631,00 | 4.385,00 | 4.158,00 | 3.321,00 | 1.143,00 | 1.782,00 | 2.640,00 | |
| EBIT-Margin5 | 12,43 | 12,09 | 11,08 | 8,13 | 5,13 | 8,16 | 11,55 | |
| Net Profit (Loss)1 | 1.915,00 | 2.823,00 | 2.819,00 | 2.117,00 | -594,00 | 471,00 | 0,00 | |
| Net-Margin6 | 5,14 | 7,78 | 7,51 | 5,18 | -2,66 | 2,16 | 0,00 | |
| Cashflow1,7 | 4.263,00 | 6.549,00 | 5.078,00 | 4.198,00 | 4.456,00 | 2.447,00 | 0,00 | |
| Earnings per share8 | 3,44 | 3,06 | 3,26 | 2,44 | -1,05 | 0,84 | 2,16 | |
| Dividend per share8 | 0,84 | 0,88 | 0,92 | 0,92 | 0,00 | 1,00 | 1,15 | |
1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de
Auditor: PricewaterhouseCoopers
All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.
| INVESTOR-INFORMATION | ||||||
| ©boersengefluester.de | ||||||
| Fresenius | ||||||
| WKN | ISIN | Legal Type | Marketcap | IPO | Recommendation | Plus Code |
| 578560 | DE0005785604 | SE & Co. KGaA | 26.956,54 Mio € | 18.12.1986 | Kaufen | 9F2C6J8F+2R |
| PE 2026e | PE 10Y-Ø | BGFL-Ratio | Shiller-PE | PB | PCF | KUV |
| 19,94 | 18,83 | 1,06 | 20,28 | 1,49 | 11,02 | 1,23 |
|
Dividend '2023 in € |
Dividend '2024 in € |
Dividend '2025e in € |
Div.-Yield '2025e in % |
| 0,00 | 1,00 | 1,15 | 2,42% |
| Annual General Meeting | Q1-figures | Q2-figures | Q3-figures | Annual press conference |
| 22.05.2026 | 06.05.2026 | 05.08.2026 | 05.11.2025 | 26.03.2025 |
| Distance 60-days-line | Distance 200-days-line | Performance YtD | Performance 52 weeks | IPO |
| +0,20% | +9,29% | +41,77% | +39,98% | +3.248,59% |
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
